Clinical Trials Browser

Phase 2 × Irinotecan × Head & Neck × Clear all

NCT00100828 2018-12-06

Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer

Phase 2 Terminated

6 enrolled 4 charts

Head and Neck Neoplasms, Thyroid Neoplasms, Carcinoma, Medullary

NCT00103259 2014-05-23

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

71 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00639769 2012-09-14

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

41 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms